A blood test that screens for multiple cancers at once promises to boost early detection

by Colin Pritchard,The ConversationDNA contains molecular patterns that indicate where in the body it came from. Credit:CNX OpenStax/Wikimedia Commons,CC BYDetecting cancer early bef

Updated on: February 20,2024

A blood test that screens for multiple cancers at once promises to boost early detection

by Colin Pritchard,The ConversationDNA contains molecular patterns that indicate where in the body it came from. Credit:CNX OpenStax/Wikimedia Commons,CC BYDetecting cancer early bef

Updated on:February 20,2024

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on: December 18,2023

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on:December 18,2023

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.

Updated on: December 26,2023

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.

Updated on:December 26,2023

Model illuminates environmental cues that may contribute to breast cancer recurrence

by Karen B. Roberts,University of DelawareUniversity of Delaware post-doctoral researcher Lina Pradham loads a protocol and plate into a bioprinter made by Inventia. Called the RASTRUM, the Inve

Updated on: December 22,2023

Model illuminates environmental cues that may contribute to breast cancer recurrence

by Karen B. Roberts,University of DelawareUniversity of Delaware post-doctoral researcher Lina Pradham loads a protocol and plate into a bioprinter made by Inventia. Called the RASTRUM, the Inve

Updated on:December 22,2023

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on: January 07,2024

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on:January 07,2024

Aspirin appears to curb colorectal cancer recurrence and tumor growth, study finds

by City of HopeCredit: CC0 Public DomainThe benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to re

Updated on: December 20,2023

Aspirin appears to curb colorectal cancer recurrence and tumor growth, study finds

by City of HopeCredit: CC0 Public DomainThe benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to re

Updated on:December 20,2023

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on: January 05,2024

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on:January 05,2024

Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici

Updated on: May 26,2024

Here's why some high-risk patients aren't getting drugs to combat COVID

by Emily Alpert Reyes, Los Angeles TimesCredit: Unsplash/CC0 Public DomainAs the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health offici

Updated on:May 26,2024

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on: December 22,2023

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on:December 22,2023

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024

Novel form of immunotherapy could revolutionize cancer treatment

by Noelle Toumey Reetz,Georgia State UniversityFig. 1: Local RT eliminates late-stage MC38 tumors in Sirpα−/− mice but not WT mice. From: Intratumoral SIRPα-deficient macrophages activate tumor

Updated on: March 25,2024

Novel form of immunotherapy could revolutionize cancer treatment

by Noelle Toumey Reetz,Georgia State UniversityFig. 1: Local RT eliminates late-stage MC38 tumors in Sirpα−/− mice but not WT mice. From: Intratumoral SIRPα-deficient macrophages activate tumor

Updated on:March 25,2024

3D genome features point to possible therapeutic target for aggressive and deadly pediatric brain tumors

by Fabienne Landry,McGill University Health CentreCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.023Posterior fossa group A (PFA) ependymoma are rare, treatment-resistant pediatric t

Updated on: July 11,2024

3D genome features point to possible therapeutic target for aggressive and deadly pediatric brain tumors

by Fabienne Landry,McGill University Health CentreCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.023Posterior fossa group A (PFA) ependymoma are rare, treatment-resistant pediatric t

Updated on:July 11,2024